Log in Start free →
Today’s CSR movers
SRE 4.1 ▲ 1.2
ES 3.0 ▲ 0.8
EIX 3.1 ▲ 0.8
AMZN 4.7 ▲ 0.1
GS 2.3 ▼ 0.8
WEC 2.6 ▼ 1.2
ETR 2.9 ▼ 1.2
C 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
FOX 2.4 ▼ 1.5
—
—
Health Care · NYSE NYSE · LH

LabCorp

$281.48 -$1.86 -0.66% CLOSE 07.20.26 AFTER HOURS $274.40
Convergence score
4.1 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Fairly Valued
Aggregated across multiple horizons
Consensus target (12mo)
$313.03 +11.2%
Range $270.00 — $340.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.20.26
UV Convergence Score
REPORT 07.20.26
4.1
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.6
Analyst average
4.4
Multi-signal aggregate How CSR works →
Day Range
$278.43 – $284.49
52W Range
$241.81 – $293.72
Volume
520.2K
Avg Vol
660.5K
Mkt Cap
$23.08B
P/E
24.95
EPS (TTM)
$11.28
Div Yield
1.02%
Beta
0.86
Today's convergence

Convergence score sits at 4.1 with overall valuation reading as fairly valued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Fairly Valued
CSR direction
STRONG BULLISH
Last close
$281.48
Sector
Health Care
Valuation
Three horizons
UPDATED 07.20.26
Short term
0–3 MO
No target Strong Buy
Medium term
3–12 MO
$314+11.7% Buy
Long term
12–36 MO
$316.75+12.5% Fairly Valued
Open valuation →
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$313.03 +11.2%
RANGE $270.00 — $340.00
Analyst consensus
Consensus rating Buy
Blended score 4.2 / 5
Analysts tracked 65
Open analysts →
Financials
Key metrics
LATEST
P/E
24.95
EPS (TTM)
$11.28
Mkt Cap
$23.08B
Div Yield
1.02%
Beta
0.86
52W Range
$241.81 – $293.72
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26
Short term
0–3 MO
Strong Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$314 +11.7%
RANGE $290 – $338
$290NOW $281.48$338

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Fairly Valued
Consensus target
$316.75 +12.5%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 24.95PEG Ratio: -DE Ratio: -
Free Cash Flow: $1.14BPB Ratio: -PS Ratio: -Dividend: $0.72
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 4.2 4 65
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $270.00 $313.03 $320.00 $340.00 +11.2%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 2 21 7 0 0
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Strong Buy 4.56 18
1 Mo Ago Strong Buy 4.56 18
2 Mo Ago Strong Buy 4.56 18
3 Mo Ago Strong Buy 4.56 18
Most recent analyst action LATEST DESK ACTION
Date
7/13/2026
Firm
Robert W. Baird
Action
Boost Target
Rating
Outperform
Target
$338.00
Related links
Financials

Full financial snapshot.

UPDATED 07.20.26
Quote snapshot 15 FIELDS
Prev Close
$283.36
Open
$281.27
Day Low
$278.43
Day High
$284.49
Bid
$279.71
Ask
$279.88
52W Low
$241.81
52W High
$293.72
50D Avg
$265.54
200D Avg
$267.31
Volume
520.2K
Avg Vol
660.5K
10D Avg Vol
558.3K
52W Change
16.59%
S&P 52W Change
18.27%
Valuation ratios 10 FIELDS
P/E (TTM)
24.95
P/E (Fwd)
14.50
PEG (Fwd)
1.20
P/S
1.63
P/B
2.65
Book Value
$106.06
EV/Revenue
2.08
EV/EBITDA
13.05
Mkt Cap
23.08B
Enterprise Val
29.41B
Profitability & returns 6 FIELDS
Profit Margin
6.66%
Gross Margin
28.83%
Operating Margin
10.94%
EBITDA Margin
15.93%
Return on Assets
5.31%
Return on Equity
11.05%
Growth 3 FIELDS
Revenue Growth (YoY)
5.80%
Earnings Growth (YoY)
32.90%
Earnings Growth (Q)
30.50%
Balance sheet & cash flow 11 FIELDS
Total Revenue
14.14B
EBITDA
2.25B
Total Cash
981.1M
Total Debt
7.29B
Cash / Share
$11.96
Revenue / Share
$170.67
Free Cash Flow
1.14B
Operating CF
1.81B
Debt / Equity
83.41
Current Ratio
1.73
Quick Ratio
1.30
Dividend 5 FIELDS
Fwd Dividend
2.88 (1.02%)
Dividend Yield
1.02%
Payout Ratio
25.51%
5Y Avg Yield
—
Ex-Div Date
2026-08-28
Share statistics 7 FIELDS
Shares Out
82M
Float
81.6M
Shares Short
2.83M
% Short of Float
3.46%
Short Ratio
4.43
% Held Insiders
0.35%
% Held Institutions
101.10%
Calendar & events 5 FIELDS
Next Earnings
2026-07-30
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-03-31
Last Split
1164:1000
Split Date
2023-07-03
Company 2 FIELDS
Industry
Diagnostics & Research
Employees
71,000